Dolina J, Lee J, Brightman S, McArdle S, Hall S, Thota R
J Clin Invest. 2023; 133(17).
PMID: 37655661
PMC: 10471175.
DOI: 10.1172/JCI164258.
Melssen M, Fisher C, Slingluff C, Melief C
J Immunother Cancer. 2023; 10(9).
PMID: 36939214
PMC: 9472143.
DOI: 10.1136/jitc-2022-004709.
Swartz A, Congdon K, Nair S, Li Q, Herndon 2nd J, Suryadevara C
NPJ Vaccines. 2021; 6(1):12.
PMID: 33462231
PMC: 7814002.
DOI: 10.1038/s41541-020-00273-5.
Filskov J, Andersen P, Agger E, Bukh J
Sci Rep. 2019; 9(1):14085.
PMID: 31575882
PMC: 6773770.
DOI: 10.1038/s41598-019-50365-z.
Lopes P, Todorov G, Pham T, Nesburn A, Bahraoui E, BenMohamed L
J Virol. 2018; 92(8).
PMID: 29437976
PMC: 5874417.
DOI: 10.1128/JVI.02156-17.
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine.
Galaine J, Borg C, Godet Y, Adotevi O
Vaccines (Basel). 2015; 3(3):490-502.
PMID: 26350591
PMC: 4586463.
DOI: 10.3390/vaccines3030490.
T cell responses to viral infections - opportunities for Peptide vaccination.
Huber S, van Beek J, de Jonge J, Luytjes W, van Baarle D
Front Immunol. 2014; 5:171.
PMID: 24795718
PMC: 3997009.
DOI: 10.3389/fimmu.2014.00171.
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.
Adotevi O, Dosset M, Galaine J, Beziaud L, Godet Y, Borg C
Hum Vaccin Immunother. 2013; 9(5):1073-7.
PMID: 23357860
PMC: 3899142.
DOI: 10.4161/hv.23587.
Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.
Chentoufi A, BenMohamed L
Clin Dev Immunol. 2013; 2012:149135.
PMID: 23320014
PMC: 3540975.
DOI: 10.1155/2012/149135.
MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.
Bobinet M, Vignard V, Rogel A, Khammari A, Dreno B, Lang F
PLoS One. 2013; 7(12):e51716.
PMID: 23284752
PMC: 3527452.
DOI: 10.1371/journal.pone.0051716.
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.
Nair S, Bayer W, Ploquin M, Kassiotis G, Hasenkrug K, Dittmer U
Retrovirology. 2011; 8:76.
PMID: 21943070
PMC: 3193819.
DOI: 10.1186/1742-4690-8-76.
A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination.
Rogel A, Vignard V, Bobinet M, Labarriere N, Lang F
Cancer Immunol Immunother. 2010; 60(3):327-37.
PMID: 21080167
PMC: 11029773.
DOI: 10.1007/s00262-010-0938-6.
Generating functional CD8+ T cell memory response under transient CD4+ T cell deficiency: implications for vaccination of immunocompromised individuals.
Smith C, Martinez M, Cooper L, Rist M, Zhong J, Khanna R
Eur J Immunol. 2008; 38(7):1857-66.
PMID: 18506880
PMC: 2478698.
DOI: 10.1002/eji.200737933.
Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
Teramoto K, Kontani K, Fujita T, Ozaki Y, Sawai S, Tezuka N
Cancer Immunol Immunother. 2006; 56(3):331-42.
PMID: 16896967
PMC: 11031089.
DOI: 10.1007/s00262-006-0192-0.
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.
McNeel D, Knutson K, Schiffman K, Davis D, Caron D, Disis M
J Clin Immunol. 2003; 23(1):62-72.
PMID: 12645861
DOI: 10.1023/a:1021904432489.
Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.
Deliyannis G, Jackson D, Ede N, Zeng W, Hourdakis I, Sakabetis E
J Virol. 2002; 76(9):4212-21.
PMID: 11932386
PMC: 155065.
DOI: 10.1128/jvi.76.9.4212-4221.2002.
Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Fayolle C, Osickova A, Osicka R, Henry T, Rojas M, Saron M
J Virol. 2001; 75(16):7330-8.
PMID: 11462005
PMC: 114968.
DOI: 10.1128/JVI.75.16.7330-7338.2001.
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.
Knutson K, Schiffman K, Disis M
J Clin Invest. 2001; 107(4):477-84.
PMID: 11181647
PMC: 199268.
DOI: 10.1172/JCI11752.
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
Dadaglio G, Moukrim Z, Lo-Man R, Sheshko V, Sebo P, Leclerc C
Infect Immun. 2000; 68(7):3867-72.
PMID: 10858196
PMC: 101660.
DOI: 10.1128/IAI.68.7.3867-3872.2000.
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C, Dadaglio G, Saron M, Deriaud E, Rojas M, Casal S
J Virol. 2000; 74(13):5769-75.
PMID: 10846055
PMC: 112070.
DOI: 10.1128/jvi.74.13.5769-5775.2000.